SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · Real-Time Price · USD

7.86

-0.17 (-2.12%)

At close: Nov 13, 2026, 4:00 PM EST

7.81

-0.05 (-0.68%)

After-hours: Nov 13, 2026, 7:59 PM EST

SLS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	134.71	71.79	13.89	2.53	17.13	21.36
Cash & Short-Term Investments	134.71	71.79	13.89	2.53	17.13	21.36
Cash Growth	203.95%	417.02%	448.85%	-85.23%	-19.81%	-39.51%
Prepaid Expenses	0.62	0.19	0.17	0.14	0.3	0.25
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.1
Other Current Assets	3.15	3.12	2.17	0.4	0.23	1.34
Total Current Assets	138.57	75.21	16.33	3.17	17.76	23.04
Property, Plant & Equipment	0.58	0.96	0.93	0.86	0.87	0.72
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Long-Term Assets	0.03	0.26	0.27	0.28	0.4	0.59
Total Assets	141.09	78.35	19.43	6.22	20.94	26.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.09	2.95	3.5	5.64	3.36	2.14
Accrued Expenses	6.51	3.48	5.42	7.61	6.29	2.48
Current Portion of Leases	0.6	0.54	0.54	0.45	0.37	0.2
Other Current Liabilities	0.09	0.04	0.04	0.04	5.5	0.16
Total Current Liabilities	9.29	7.02	9.51	13.74	15.52	4.98
Long-Term Leases	-	0.46	0.46	0.46	0.57	0.61
Other Long-Term Liabilities	-	-	-	-	0	0.34
Total Liabilities	9.29	7.47	9.97	14.2	16.09	5.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0	0	0
Additional Paid-In Capital	434.88	345.84	257.58	209.27	184.75	158.95
Retained Earnings	-303.09	-274.99	-248.13	-217.24	-179.9	-138.6
Shareholders' Equity	131.81	70.87	9.47	-7.98	4.85	20.35
Total Liabilities & Equity	141.09	78.35	19.43	6.22	20.94	26.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.6	1	1	0.91	0.95	0.81
Net Cash (Debt)	134.11	70.79	12.89	1.62	16.18	20.55
Net Cash Growth	206.75%	449.41%	693.41%	-89.96%	-21.25%	-40.12%
Net Cash Per Share	0.76	0.65	0.21	0.06	0.83	1.33
Filing Date Shares Outstanding	203.86	179.58	90.85	56.27	28.3	15.91
Total Common Shares Outstanding	203.53	153.1	73.98	32.13	21.01	15.9
Working Capital	129.29	68.19	6.82	-10.56	2.24	18.06
Book Value Per Share	0.65	0.46	0.13	-0.25	0.23	1.28
Tangible Book Value	129.89	68.96	7.55	-9.89	2.94	18.43
Tangible Book Value Per Share	0.64	0.45	0.10	-0.31	0.14	1.16

SEC Filings: 10-K · 10-Q